Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Diphenhydramine overdose

Antimuscarinic delirium following drug toxicity: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Whitledge JD, et al. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine. Journal of Medical Toxicology - official journal of the American College of Medical Toxicology 19: 219-223, No. 2, Apr 2023. Available from: URL: http://doi.org/10.1007/s13181-022-00925-z Whitledge JD, et al. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine. Journal of Medical Toxicology - official journal of the American College of Medical Toxicology 19: 219-223, No. 2, Apr 2023. Available from: URL: http://​doi.​org/​10.​1007/​s13181-022-00925-z
Metadaten
Titel
Diphenhydramine overdose
Antimuscarinic delirium following drug toxicity: case report
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49526-9

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Antineoplastics

Case report

Pembrolizumab

Case report

Multiple drugs